The Center for Innovation & Value Research Releases Blueprint for Patient-Centered Value Research

Key Takeaways

The Blueprint emphasizes patient involvement in shaping research, enhancing relevance and trustworthiness of healthcare evidence.
It offers practical strategies for patients, researchers, policymakers, and health leaders to integrate patient perspectives.
Designed to foster inclusive, multi-stakeholder collaboration, it aims to transform evidence generation and application in healthcare.
The resource sets a new standard for health technology assessment, promoting equitable, community-informed decision-making.

Alexandria, VA – July 16, 2025 –The Center for Innovation & Value Research (the Center), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, is proud to announce the release of a new foundational resource: The Blueprint for Patient-Centered Value Research.

Co-developed with community leaders, researchers, and policy experts, the Blueprint provides practical guidance on embedding patient perspectives throughout the research lifecycle, from study design to implementation and impact. It serves as a roadmap for building more equitable, transparent, and responsive healthcare research and decision-making systems.

“The Blueprint is rooted in the idea that patients should not only be the subject of research, but they should also help shape it,” said Rick Chapman, PhD, Chief Science Officer at the Center for Innovation & Value Research. “By centering patient priorities and experiences, we can create more relevant, trustworthy, and equitable evidence to inform healthcare decisions.”

The Blueprint is designed for use across the healthcare ecosystem and provides actionable strategies for a wide range of stakeholders:

For Patients and Patient Advocates: Tools and language to advocate for meaningful involvement in setting research agendas and defining value.
For Researchers and Academics: Frameworks to design inclusive studies that better capture real-world experiences and outcomes.
For Policymakers and Regulatory Bodies: Guidance to support equitable decision-making grounded in community-informed evidence.
For Payers and Health System Leaders: Recommendations for integrating patient-defined value into coverage, access, and investment decisions.

The Blueprint sets a new standard for health technology assessment and value frameworks by offering a shared foundation for inclusive, multi-stakeholder collaboration. It is intended to drive long-term change in how evidence is generated, evaluated, and applied in healthcare policy and practice.

The Blueprint is now available for download here.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!